XBI

Fund Description
The SPDR S&P Biotech ETF before expenses seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index (ticker: SPSIBITR).
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotech Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 June 2019
Asset Under Management 4452.43 Million (USD)
1 Month Total Return 5.54 %
Year To Date Return 21.62 %
1 Year Total Return -13.65 %
3 Year Annualized Total Return 17.45 %
NAV 87.1318
Share Outstanding 51,100,000
Top 10 Holdings (21 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ARRAY BIOPHARMA INC ARRY EQUI 0.0209135100
GLOBAL BLOOD THERAPEUTICS IN GBT EQUI 0.0156331000
INCYTE CORP INCY EQUI 0.0152890800
ALEXION PHARMACEUTICALS INC ALXN EQUI 0.0150358000
INVITAE CORP NVTA EQUI 0.0150107600
CLOVIS ONCOLOGY INC CLVS EQUI 0.0149573100
ULTRAGENYX PHARMACEUTICAL IN RARE EQUI 0.0146687900
AMICUS THERAPEUTICS INC FOLD EQUI 0.0146218100
FIBROGEN INC FGEN EQUI 0.0145895800
BIOMARIN PHARMACEUTICAL INC BMRN EQUI 0.0145669400